Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis

Human Pathology

Volumn 45, Issue 11, 2014, Pages 2202-2210

  Kempf, Werner ^a   Zollinger, Therese ^a   Sachs, Melanie ^b   Ullmer, Elke ^b   Cathomas, Gieri ^b   Dirnhofer, Stephan ^c   Mertz, Kirsten D ^b,d  

^a Research Unit   (Switzerland)

^b Kantonsspital Liestal   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Biomarker; Granuloma; Immunohistochemistry; Interleukin 33; Macrophage; Sarcoidosis

Indexed keywords

BIOLOGICAL MARKER; CD163 ANTIGEN; INTERLEUKIN 33; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIOID CELL; FEMALE; FOREIGN BODY GRANULOMA; GIANT CELL; GRANULOMA; GRANULOMA ANNULARE; GRANULOMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG BIOPSY; LUNG GRANULOMATOSIS; LUNG SARCOIDOSIS; MACROPHAGE; MALE; PHENOTYPE; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN GRANULOMA; SYSTEMIC DISEASE; TUBERCULOSIS; TULAREMIA; TUMOR MICROENVIRONMENT; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; SARCOIDOSIS; SKIN DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; MALE; MIDDLE AGED; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SKIN DISEASES; YOUNG ADULT;

EID: 84908312861     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.07.011     Document Type: Article

References (34)

1. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
2. A. Zumla, and D.G. James Granulomatous infections: etiology and classification Clin Infect Dis 23 1996 146 158
3. A. Bergeron, M. Bonay, and M. Kambouchner Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response J Immunol 159 1997 3034 3043
4. S. Prokop, F.L. Heppner, H.H. Goebel, and W. Stenzel M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis Am J Pathol 178 2011 1279 1286
5. E.S. Chen, and D.R. Moller Sarcoidosis-scientific progress and clinical challenges Nat Rev Rheumatol 7 2011 457 467
6. A.K. Gerke, and G. Hunninghake The immunology of sarcoidosis Clin Chest Med 29 2008 379 390
7. A.A. Chackerian, E.R. Oldham, E.E. Murphy, J. Schmitz, S. Pflanz, and R.A. Kastelein IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex J Immunol 179 2007 2551 2555
8. J. Schmitz, A. Owyang, and E. Oldham IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
9. C. Moussion, N. Ortega, and J.P. Girard The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 3 2008 e3331
10. M. Kurowska-Stolarska, P. Kewin, and G. Murphy IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4 J Immunol 181 2008 4780 4790
11. M.D. Smithgall, M.R. Comeau, B.R. Yoon, D. Kaufman, R. Armitage, and D.E. Smith IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells Int Immunol 20 2008 1019 1030
12. Z. Allakhverdi, D.E. Smith, M.R. Comeau, and G. Delespesse Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells J Immunol 179 2007 2051 2054
13. F. Ciccia, R. Alessandro, and A. Rizzo IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis Ann Rheum Dis 72 2013 258 264
14. V. Carriere, L. Roussel, and N. Ortega IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci U S A 104 2007 282 287
15. M. Pichery, E. Mirey, and P. Mercier Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain J Immunol 188 2012 3488 3495
16. M.A. Sedhom, M. Pichery, and J.R. Murdoch Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice Gut 62 2013 1714 1723
17. J. Sponheim, J. Pollheimer, and T. Olsen Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts Am J Pathol 177 2010 2804 2815
18. G.W. Hunninghake, U. Costabel, and M. Ando ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 16 1999 149 173
19. V. Palchevskiy, N. Hashemi, and S.S. Weigt Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis Fibrogenesis Tissue Repair 4 2011 10
20. H.P. Hauber, D. Gholami, A. Meyer, and A. Pforte Increased interleukin-13 expression in patients with sarcoidosis Thorax 58 2003 519 524
21. E. Abe, Y. Ishimi, C.H. Jin, M.H. Hong, T. Sato, and T. Suda Granulocyte-macrophage colony-stimulating factor is a major macrophage fusion factor present in conditioned medium of concanavalin A-stimulated spleen cell cultures J Immunol 147 1991 1810 1815
22. U. Seitzer, H. Haas, and J. Gerdes A human in vitro granuloma model for the investigation of multinucleated giant cell and granuloma formation Histol Histopathol 16 2001 645 653
23. L. Helming, and S. Gordon Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules Eur J Immunol 37 2007 33 42
24. A. Prasse, D.V. Pechkovsky, and G.B. Toews A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 Am J Respir Crit Care Med 173 2006 781 792
25. M.T. Henry, K. McMahon, and A.J. Mackarel Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Eur Respir J 20 2002 1220 1227
26. G. Zissel, A. Prasse, and J. Muller-Quernheim Immunologic response of sarcoidosis Semin Respir Crit Care Med 31 2010 390 403
27. J.A. Elias, B. Freundlich, J.A. Kern, and J. Rosenbloom Cytokine networks in the regulation of inflammation and fibrosis in the lung Chest 97 1990 1439 1445
28. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
29. A. Mantovani, and A. Sica Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr Opin Immunol 22 2010 231 237
30. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 2012 787 795
31. T.A. Wynn, and L. Barron Macrophages: master regulators of inflammation and fibrosis Semin Liver Dis 30 2010 245 257
32. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964
33. X. Liu, M. Li, Y. Wu, Y. Zhou, L. Zeng, and T. Huang Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma Biochem Biophys Res Commun 386 2009 181 185
34. G. Palmer, D. Talabot-Ayer, and C. Lamacchia Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis Arthritis Rheum 60 2009 738 749